Liu Y, Zhou F, Ali H, Lathia J, Chen P
Cell Mol Immunol. 2024; 21(12):1354-1375.
PMID: 39406966
PMC: 11607068.
DOI: 10.1038/s41423-024-01226-x.
Du T, Raghunandan A, Mestre H, Pla V, Liu G, Ladron-de-Guevara A
Nat Aging. 2024; 4(10):1418-1431.
PMID: 39147980
DOI: 10.1038/s43587-024-00691-3.
Mokbel A, Burns M, Main B
J Neuroinflammation. 2024; 21(1):135.
PMID: 38802931
PMC: 11131220.
DOI: 10.1186/s12974-024-03122-7.
Chen X, Cui Y, Zou L
Front Oncol. 2024; 14:1287725.
PMID: 38660136
PMC: 11039916.
DOI: 10.3389/fonc.2024.1287725.
Duan M, Xu Y, Li Y, Feng H, Chen Y
J Neuroinflammation. 2024; 21(1):102.
PMID: 38637850
PMC: 11025216.
DOI: 10.1186/s12974-024-03101-y.
Olfactory immunology: the missing piece in airway and CNS defence.
Wellford S, Moseman E
Nat Rev Immunol. 2023; 24(6):381-398.
PMID: 38097777
PMC: 11560121.
DOI: 10.1038/s41577-023-00972-9.
An injectable signal-amplifying device elicits a specific immune response against malignant glioblastoma.
Qiu Q, Chen S, He H, Chen J, Ding X, Wang D
Acta Pharm Sin B. 2023; 13(12):5091-5106.
PMID: 38045037
PMC: 10692361.
DOI: 10.1016/j.apsb.2023.06.010.
Immune cells as messengers from the CNS to the periphery: the role of the meningeal lymphatic system in immune cell migration from the CNS.
Laaker C, Baenen C, Kovacs K, Sandor M, Fabry Z
Front Immunol. 2023; 14:1233908.
PMID: 37662908
PMC: 10471710.
DOI: 10.3389/fimmu.2023.1233908.
Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults.
Olivet M, Brown M, Reitman Z, Ashley D, Grant G, Yang Y
Cancers (Basel). 2023; 15(15).
PMID: 37568717
PMC: 10416859.
DOI: 10.3390/cancers15153901.
New trends in brain tumor immunity with the opportunities of lymph nodes targeted drug delivery.
Qi Y, Xiong W, Chen Q, Ye Z, Jiang C, He Y
J Nanobiotechnology. 2023; 21(1):254.
PMID: 37542241
PMC: 10401854.
DOI: 10.1186/s12951-023-02011-0.
Natural Products for the Immunotherapy of Glioma.
Huang Q, Pan X, Zhu W, Zhao W, Xu H, Hu K
Nutrients. 2023; 15(12).
PMID: 37375698
PMC: 10302066.
DOI: 10.3390/nu15122795.
Nanomaterials with dual immunomodulatory functions for synergistic therapy of breast cancer brain metastases.
Zhao Z, Li C, Zhang Y, Li C, Chu Y, Li X
Bioact Mater. 2023; 27:474-487.
PMID: 37159612
PMC: 10163467.
DOI: 10.1016/j.bioactmat.2023.04.021.
Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA.
Celesti F, Gatta A, Shallak M, Chiaravalli A, Cerati M, Sessa F
Front Immunol. 2023; 14:1133177.
PMID: 36993983
PMC: 10040613.
DOI: 10.3389/fimmu.2023.1133177.
Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect.
Deng H, Zhang J, Wu F, Wei F, Han W, Xu X
Cancers (Basel). 2023; 15(4).
PMID: 36831512
PMC: 9954532.
DOI: 10.3390/cancers15041169.
Meningeal lymphatic drainage promotes T cell responses against but is dispensable for parasite control in the brain.
Kovacs M, Cowan M, Babcock I, Sibley L, Still K, Batista S
Elife. 2022; 11.
PMID: 36541708
PMC: 9812409.
DOI: 10.7554/eLife.80775.
The lymphatic system: a therapeutic target for central nervous system disorders.
Xu J, Liu Q, Huang S, Duan C, Lu H, Cao Y
Neural Regen Res. 2022; 18(6):1249-1256.
PMID: 36453401
PMC: 9838139.
DOI: 10.4103/1673-5374.355741.
Targeting PP2A for cancer therapeutic modulation.
Ronk H, Rosenblum J, Kung T, Zhuang Z
Cancer Biol Med. 2022; 19(10).
PMID: 36342229
PMC: 9630519.
DOI: 10.20892/j.issn.2095-3941.2022.0330.
New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders: Combining with intranasal delivery.
Li Y, Wu H, Jiang X, Dong Y, Zheng J, Gao J
Acta Pharm Sin B. 2022; 12(8):3215-3232.
PMID: 35967290
PMC: 9366301.
DOI: 10.1016/j.apsb.2022.04.001.
CD4 CD8 T Cells Home to the Brain and Mediate HIV Neuroinvasion.
Albalawi Y, Narasipura S, Olivares L, Al-Harthi L
J Virol. 2022; 96(15):e0080422.
PMID: 35852355
PMC: 9364807.
DOI: 10.1128/jvi.00804-22.
The Olfactory Organ Is a Unique Site for Neutrophils in the Brain.
Palominos M, Calfun C, Nardocci G, Candia D, Torres-Paz J, Whitlock K
Front Immunol. 2022; 13:881702.
PMID: 35693773
PMC: 9186071.
DOI: 10.3389/fimmu.2022.881702.